As the Connected Health Conference — formerly known as the mHealth Summit — gets underway in National Harbor, Maryland, the organization that puts it on, the Personal Connected Health Alliance, is taking part in a merger of sorts.
Edwards Lifesciences is paying up to $690 million to a buy an Israeli company that makes transcatheter mitral valve and tricuspid repair devices. Last year it bought a mitral valve replacement company for about $400 million.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Ozark, Missouri-based HealthMEDX serves retirement communities, assisted-living and independent-living facilities, skilled nursing centers and home care providers.
The all-cash deal will give Wolters Kluwer a more complete suite of health information products and allow Emmi to gain a foothold in international markets.
The new Salus Telehealth brings together a traditional telehealth and remote monitoring platform from Salus and a mobile app from VideoMedicine that connects consumers to physicians, including specialists.
Fast Company said that Gliimpse makes "a personal health data platform that enables any American to collect, personalize and share a picture of their health data." Haven't we seen this movie before?
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Pfizer would be acquiring Xtandi, a blockbuster treatment for prostate cancer that is expected to generate annual sales of $1.33 billion by 2020, according to Bloomberg.
The deal will privatize South Bend, Indiana-based Press Ganey just 16 months after it had gone public.
Coverys, which collects $420 million in malpractice premiums annually, has now completed five acquisitions in the last two years.
The two companies are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The deal will give Huron Consulting coverage of "virtually the full range" of commercial electronic health record products, the company said.
The companies disagreed, though some more strongly than others. All four have vowed to defend their planned mergers in court.
The deal will allow Amsterdam-based Philips to augment its offerings in population health management.
“It was driven by the recognition that fundamentally the biological platform for both companies was a mirror image. We both independently uncovered the biology of the immune-microbiome.”
“It took time to make sure the service was ready,” Ron Gutman, HealthTap founder and CEO, said. “We made the announcement when they were ready and can serve our physicians well and patients well.”